Copyright Reports & Markets. All rights reserved.

Global Nuclear Receptor ROR Gamma Market Professional Survey Report 2019

Request for Sample of this report
Buy now

Table of Contents

    Executive Summary

      1 Industry Overview of Nuclear Receptor ROR Gamma

      • 1.1 Definition of Nuclear Receptor ROR Gamma
      • 1.2 Nuclear Receptor ROR Gamma Segment by Type
        • 1.2.1 Global Nuclear Receptor ROR Gamma Production Growth Rate Comparison by Types (2014-2025)
        • 1.2.2 BBI-6000
        • 1.2.3 GRC-39815Action
        • 1.2.4 R&D Progress
        • 1.2.5 GSK-2981278
        • 1.2.6 IMU-366
        • 1.2.7 INV-17
        • 1.2.8 Others
      • 1.3 Nuclear Receptor ROR Gamma Segment by Applications
        • 1.3.1 Global Nuclear Receptor ROR Gamma Consumption Comparison by Applications (2014-2025)
        • 1.3.2 Chronic Obstructive Pulmonary Disease
        • 1.3.3 Asthma
        • 1.3.4 Axial Spondyloarthritis
        • 1.3.5 Breast Cancer
        • 1.3.6 Others
      • 1.4 Global Nuclear Receptor ROR Gamma Overall Market
        • 1.4.1 Global Nuclear Receptor ROR Gamma Revenue (2014-2025)
        • 1.4.2 Global Nuclear Receptor ROR Gamma Production (2014-2025)
        • 1.4.3 North America Nuclear Receptor ROR Gamma Status and Prospect (2014-2025)
        • 1.4.4 Europe Nuclear Receptor ROR Gamma Status and Prospect (2014-2025)
        • 1.4.5 China Nuclear Receptor ROR Gamma Status and Prospect (2014-2025)
        • 1.4.6 Japan Nuclear Receptor ROR Gamma Status and Prospect (2014-2025)
        • 1.4.7 Southeast Asia Nuclear Receptor ROR Gamma Status and Prospect (2014-2025)
        • 1.4.8 India Nuclear Receptor ROR Gamma Status and Prospect (2014-2025)

      2 Manufacturing Cost Structure Analysis

      • 2.1 Raw Material and Suppliers
      • 2.2 Manufacturing Cost Structure Analysis of Nuclear Receptor ROR Gamma
      • 2.3 Manufacturing Process Analysis of Nuclear Receptor ROR Gamma
      • 2.4 Industry Chain Structure of Nuclear Receptor ROR Gamma

      3 Development and Manufacturing Plants Analysis of Nuclear Receptor ROR Gamma

      • 3.1 Capacity and Commercial Production Date
      • 3.2 Global Nuclear Receptor ROR Gamma Manufacturing Plants Distribution
      • 3.3 Major Manufacturers Technology Source and Market Position of Nuclear Receptor ROR Gamma
      • 3.4 Recent Development and Expansion Plans

      4 Key Figures of Major Manufacturers

      • 4.1 Nuclear Receptor ROR Gamma Production and Capacity Analysis
      • 4.2 Nuclear Receptor ROR Gamma Revenue Analysis
      • 4.3 Nuclear Receptor ROR Gamma Price Analysis
      • 4.4 Market Concentration Degree

      5 Nuclear Receptor ROR Gamma Regional Market Analysis

      • 5.1 Nuclear Receptor ROR Gamma Production by Regions
        • 5.1.1 Global Nuclear Receptor ROR Gamma Production by Regions
        • 5.1.2 Global Nuclear Receptor ROR Gamma Revenue by Regions
      • 5.2 Nuclear Receptor ROR Gamma Consumption by Regions
      • 5.3 North America Nuclear Receptor ROR Gamma Market Analysis
        • 5.3.1 North America Nuclear Receptor ROR Gamma Production
        • 5.3.2 North America Nuclear Receptor ROR Gamma Revenue
        • 5.3.3 Key Manufacturers in North America
        • 5.3.4 North America Nuclear Receptor ROR Gamma Import and Export
      • 5.4 Europe Nuclear Receptor ROR Gamma Market Analysis
        • 5.4.1 Europe Nuclear Receptor ROR Gamma Production
        • 5.4.2 Europe Nuclear Receptor ROR Gamma Revenue
        • 5.4.3 Key Manufacturers in Europe
        • 5.4.4 Europe Nuclear Receptor ROR Gamma Import and Export
      • 5.5 China Nuclear Receptor ROR Gamma Market Analysis
        • 5.5.1 China Nuclear Receptor ROR Gamma Production
        • 5.5.2 China Nuclear Receptor ROR Gamma Revenue
        • 5.5.3 Key Manufacturers in China
        • 5.5.4 China Nuclear Receptor ROR Gamma Import and Export
      • 5.6 Japan Nuclear Receptor ROR Gamma Market Analysis
        • 5.6.1 Japan Nuclear Receptor ROR Gamma Production
        • 5.6.2 Japan Nuclear Receptor ROR Gamma Revenue
        • 5.6.3 Key Manufacturers in Japan
        • 5.6.4 Japan Nuclear Receptor ROR Gamma Import and Export
      • 5.7 Southeast Asia Nuclear Receptor ROR Gamma Market Analysis
        • 5.7.1 Southeast Asia Nuclear Receptor ROR Gamma Production
        • 5.7.2 Southeast Asia Nuclear Receptor ROR Gamma Revenue
        • 5.7.3 Key Manufacturers in Southeast Asia
        • 5.7.4 Southeast Asia Nuclear Receptor ROR Gamma Import and Export
      • 5.8 India Nuclear Receptor ROR Gamma Market Analysis
        • 5.8.1 India Nuclear Receptor ROR Gamma Production
        • 5.8.2 India Nuclear Receptor ROR Gamma Revenue
        • 5.8.3 Key Manufacturers in India
        • 5.8.4 India Nuclear Receptor ROR Gamma Import and Export

      6 Nuclear Receptor ROR Gamma Segment Market Analysis (by Type)

      • 6.1 Global Nuclear Receptor ROR Gamma Production by Type
      • 6.2 Global Nuclear Receptor ROR Gamma Revenue by Type
      • 6.3 Nuclear Receptor ROR Gamma Price by Type

      7 Nuclear Receptor ROR Gamma Segment Market Analysis (by Application)

      • 7.1 Global Nuclear Receptor ROR Gamma Consumption by Application
      • 7.2 Global Nuclear Receptor ROR Gamma Consumption Market Share by Application (2014-2019)

      8 Nuclear Receptor ROR Gamma Major Manufacturers Analysis

      • 8.1 Genfit SA
        • 8.1.1 Genfit SA Nuclear Receptor ROR Gamma Production Sites and Area Served
        • 8.1.2 Genfit SA Product Introduction, Application and Specification
        • 8.1.3 Genfit SA Nuclear Receptor ROR Gamma Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.1.4 Main Business and Markets Served
      • 8.2 GlaxoSmithKline Plc
        • 8.2.1 GlaxoSmithKline Plc Nuclear Receptor ROR Gamma Production Sites and Area Served
        • 8.2.2 GlaxoSmithKline Plc Product Introduction, Application and Specification
        • 8.2.3 GlaxoSmithKline Plc Nuclear Receptor ROR Gamma Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.2.4 Main Business and Markets Served
      • 8.3 Aurigene Discovery Technologies Ltd
        • 8.3.1 Aurigene Discovery Technologies Ltd Nuclear Receptor ROR Gamma Production Sites and Area Served
        • 8.3.2 Aurigene Discovery Technologies Ltd Product Introduction, Application and Specification
        • 8.3.3 Aurigene Discovery Technologies Ltd Nuclear Receptor ROR Gamma Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.3.4 Main Business and Markets Served
      • 8.4 Beijing Hanmi Pharmaceutical Co Ltd
        • 8.4.1 Beijing Hanmi Pharmaceutical Co Ltd Nuclear Receptor ROR Gamma Production Sites and Area Served
        • 8.4.2 Beijing Hanmi Pharmaceutical Co Ltd Product Introduction, Application and Specification
        • 8.4.3 Beijing Hanmi Pharmaceutical Co Ltd Nuclear Receptor ROR Gamma Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.4.4 Main Business and Markets Served
      • 8.5 Biogen Inc
        • 8.5.1 Biogen Inc Nuclear Receptor ROR Gamma Production Sites and Area Served
        • 8.5.2 Biogen Inc Product Introduction, Application and Specification
        • 8.5.3 Biogen Inc Nuclear Receptor ROR Gamma Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.5.4 Main Business and Markets Served
      • 8.6 AbbVie Inc
        • 8.6.1 AbbVie Inc Nuclear Receptor ROR Gamma Production Sites and Area Served
        • 8.6.2 AbbVie Inc Product Introduction, Application and Specification
        • 8.6.3 AbbVie Inc Nuclear Receptor ROR Gamma Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.6.4 Main Business and Markets Served
      • 8.7 Advinus Therapeutics Ltd
        • 8.7.1 Advinus Therapeutics Ltd Nuclear Receptor ROR Gamma Production Sites and Area Served
        • 8.7.2 Advinus Therapeutics Ltd Product Introduction, Application and Specification
        • 8.7.3 Advinus Therapeutics Ltd Nuclear Receptor ROR Gamma Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.7.4 Main Business and Markets Served
      • 8.8 Brickell Biotech Inc
        • 8.8.1 Brickell Biotech Inc Nuclear Receptor ROR Gamma Production Sites and Area Served
        • 8.8.2 Brickell Biotech Inc Product Introduction, Application and Specification
        • 8.8.3 Brickell Biotech Inc Nuclear Receptor ROR Gamma Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.8.4 Main Business and Markets Served
      • 8.9 Pfizer Inc
        • 8.9.1 Pfizer Inc Nuclear Receptor ROR Gamma Production Sites and Area Served
        • 8.9.2 Pfizer Inc Product Introduction, Application and Specification
        • 8.9.3 Pfizer Inc Nuclear Receptor ROR Gamma Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.9.4 Main Business and Markets Served
      • 8.10 Phenex Pharmaceuticals AG
        • 8.10.1 Phenex Pharmaceuticals AG Nuclear Receptor ROR Gamma Production Sites and Area Served
        • 8.10.2 Phenex Pharmaceuticals AG Product Introduction, Application and Specification
        • 8.10.3 Phenex Pharmaceuticals AG Nuclear Receptor ROR Gamma Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.10.4 Main Business and Markets Served
      • 8.11 Reata Pharmaceuticals Inc
      • 8.12 Bristol-Myers Squibb Company
      • 8.13 Celgene Corp
      • 8.14 Eli Lilly and Company
      • 8.15 Glenmark Pharmaceuticals Ltd
      • 8.16 Lead Pharma Holding BV

      9 Development Trend of Analysis of Nuclear Receptor ROR Gamma Market

      • 9.1 Global Nuclear Receptor ROR Gamma Market Trend Analysis
        • 9.1.1 Global Nuclear Receptor ROR Gamma Market Size (Volume and Value) Forecast 2019-2025
      • 9.2 Nuclear Receptor ROR Gamma Regional Market Trend
        • 9.2.1 North America Nuclear Receptor ROR Gamma Forecast 2019-2025
        • 9.2.2 Europe Nuclear Receptor ROR Gamma Forecast 2019-2025
        • 9.2.3 China Nuclear Receptor ROR Gamma Forecast 2019-2025
        • 9.2.4 Japan Nuclear Receptor ROR Gamma Forecast 2019-2025
        • 9.2.5 Southeast Asia Nuclear Receptor ROR Gamma Forecast 2019-2025
        • 9.2.6 India Nuclear Receptor ROR Gamma Forecast 2019-2025
      • 9.3 Nuclear Receptor ROR Gamma Market Trend (Product Type)
      • 9.4 Nuclear Receptor ROR Gamma Market Trend (Application)
      • 10.1 Marketing Channel
        • 10.1.1 Direct Marketing
        • 10.1.2 Indirect Marketing
      • 10.3 Nuclear Receptor ROR Gamma Customers

      11 Market Dynamics

      • 11.1 Market Trends
      • 11.2 Opportunities
      • 11.3 Market Drivers
      • 11.4 Challenges
      • 11.5 Influence Factors

      12 Conclusion

        13 Appendix

        • 13.1 Methodology/Research Approach
          • 13.1.1 Research Programs/Design
          • 13.1.2 Market Size Estimation
          • 13.1.3 Market Breakdown and Data Triangulation
        • 13.2 Data Source
          • 13.2.1 Secondary Sources
          • 13.2.2 Primary Sources
        • 13.3 Author List

        The global Nuclear Receptor ROR Gamma market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025.
        This report focuses on Nuclear Receptor ROR Gamma volume and value at global level, regional level and company level. From a global perspective, this report represents overall Nuclear Receptor ROR Gamma market size by analyzing historical data and future prospect.
        Regionally, this report categorizes the production, apparent consumption, export and import of Nuclear Receptor ROR Gamma in North America, Europe, China, Japan, Southeast Asia and India.
        For each manufacturer covered, this report analyzes their Nuclear Receptor ROR Gamma manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.

        The following manufacturers are covered:
        Genfit SA
        GlaxoSmithKline Plc
        Aurigene Discovery Technologies Ltd
        Beijing Hanmi Pharmaceutical Co Ltd
        Biogen Inc
        AbbVie Inc
        Advinus Therapeutics Ltd
        Brickell Biotech Inc
        Pfizer Inc
        Phenex Pharmaceuticals AG
        Reata Pharmaceuticals Inc
        Bristol-Myers Squibb Company
        Celgene Corp
        Eli Lilly and Company
        Glenmark Pharmaceuticals Ltd
        Lead Pharma Holding BV

        Segment by Regions
        North America
        Europe
        China
        Japan
        Southeast Asia
        India

        Segment by Type
        BBI-6000
        GRC-39815Action
        R&D Progress
        GSK-2981278
        IMU-366
        INV-17
        Others

        Segment by Application
        Chronic Obstructive Pulmonary Disease
        Asthma
        Axial Spondyloarthritis
        Breast Cancer
        Others

        Buy now